53 related articles for article (PubMed ID: 18082233)
1. Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
Mbacham WF; Evehe MS; Netongo PM; Ateh IA; Mimche PN; Ajua A; Nji AM; Irenee D; Echouffo-Tcheugui JB; Tawe B; Hallett R; Roper C; Targett G; Greenwood B
Malar J; 2010 Jan; 9():34. PubMed ID: 20105282
[TBL] [Abstract][Full Text] [Related]
2. Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.
Beavogui AH; Djimde AA; Gregson A; Toure AM; Dao A; Coulibaly B; Ouologuem D; Fofana B; Sacko A; Tekete M; Kone A; Niare O; Wele M; Plowe CV; Picot S; Doumbo OK
Int J Parasitol; 2010 Aug; 40(10):1213-20. PubMed ID: 20460125
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali.
Maiga H; Djimde AA; Beavogui AH; Toure O; Tekete M; Sangare CP; Dara A; Traore ZI; Traore OB; Dama S; N'Dong C; Niangaly H; Diallo N; Dembele D; Sagara I; Doumbo OK
Malar J; 2015 Feb; 14():64. PubMed ID: 25889633
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi.
Ravenhall M; Benavente ED; Mipando M; Jensen AT; Sutherland CJ; Roper C; Sepúlveda N; Kwiatkowski DP; Montgomery J; Phiri KS; Terlouw A; Craig A; Campino S; Ocholla H; Clark TG
Malar J; 2016 Nov; 15(1):575. PubMed ID: 27899115
[TBL] [Abstract][Full Text] [Related]
5. Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
Konaté AT; Yaro JB; Ouédraogo AZ; Diarra A; Gansané A; Soulama I; Kangoyé DT; Kaboré Y; Ouédraogo E; Ouédraogo A; Tiono AB; Ouédraogo IN; Chandramohan D; Cousens S; Milligan PJ; Sirima SB; Greenwood BM; Diallo DA
PLoS One; 2011; 6(8):e23391. PubMed ID: 21858097
[TBL] [Abstract][Full Text] [Related]
6. Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
Dicko A; Barry A; Dicko M; Diallo AI; Tembine I; Dicko Y; Dara N; Sidibe Y; Santara G; Conaré T; Chandramohan D; Cousens S; Milligan PJ; Diallo DA; Doumbo OK; Greenwood B
PLoS One; 2011; 6(8):e23390. PubMed ID: 21858096
[TBL] [Abstract][Full Text] [Related]
7. Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial.
Senn N; Rarau P; Stanisic DI; Robinson L; Barnadas C; Manong D; Salib M; Iga J; Tarongka N; Ley S; Rosanas-Urgell A; Aponte JJ; Zimmerman PA; Beeson JG; Schofield L; Siba P; Rogerson SJ; Reeder JC; Mueller I
PLoS Med; 2012; 9(3):e1001195. PubMed ID: 22479155
[TBL] [Abstract][Full Text] [Related]
8. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease.
Thera MA; Sehdev PS; Coulibaly D; Traore K; Garba MN; Cissoko Y; Kone A; Guindo A; Dicko A; Beavogui AH; Djimde AA; Lyke KE; Diallo DA; Doumbo OK; Plowe CV
J Infect Dis; 2005 Nov; 192(10):1823-9. PubMed ID: 16235184
[TBL] [Abstract][Full Text] [Related]
9. Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso.
Bisoffi Z; Tinto H; Sirima BS; Gobbi F; Angheben A; Buonfrate D; Van den Ende J
PLoS One; 2013; 8(3):e58019. PubMed ID: 23472129
[TBL] [Abstract][Full Text] [Related]
10. The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector.
Amin AA; Snow RW; Kokwaro GO
J Clin Pharm Ther; 2005 Dec; 30(6):559-65. PubMed ID: 16336288
[TBL] [Abstract][Full Text] [Related]
11. Impact of training in clinical and microscopy diagnosis of childhood malaria on antimalarial drug prescription and health outcome at primary health care level in Tanzania: a randomized controlled trial.
Ngasala B; Mubi M; Warsame M; Petzold MG; Massele AY; Gustafsson LL; Tomson G; Premji Z; Bjorkman A
Malar J; 2008 Oct; 7():199. PubMed ID: 18831737
[TBL] [Abstract][Full Text] [Related]
12. Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.
Juliano JJ; Giesbrecht DJ; Simkin A; Fola AA; Lyimo BM; Pereus D; Bakari C; Madebe RA; Seth MD; Mandara CI; Popkin-Hall ZR; Moshi R; Mbwambo RB; Niaré K; MacInnis B; Francis F; Mbwambo D; Garimo I; Chacky F; Aaron S; Lusasi A; Molteni F; Njau RJA; Lazaro S; Mohamed A; Bailey JA; Ishengoma DS
medRxiv; 2023 Nov; ():. PubMed ID: 37986920
[TBL] [Abstract][Full Text] [Related]
13. Presumptive treatment to reduce imported malaria among refugees from east Africa resettling in the United States.
Phares CR; Kapella BK; Doney AC; Arguin PM; Green M; Mekonnen L; Galev A; Weinberg M; Stauffer WM
Am J Trop Med Hyg; 2011 Oct; 85(4):612-5. PubMed ID: 21976559
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
[TBL] [Abstract][Full Text] [Related]
15. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
[TBL] [Abstract][Full Text] [Related]
18. Antifolates can have a role in the treatment of Plasmodium vivax.
Hawkins VN; Joshi H; Rungsihirunrat K; Na-Bangchang K; Sibley CH
Trends Parasitol; 2007 May; 23(5):213-22. PubMed ID: 17368986
[TBL] [Abstract][Full Text] [Related]
19. Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?
Nzila A; Ochong E; Nduati E; Gilbert K; Winstanley P; Ward S; Marsh K
Trans R Soc Trop Med Hyg; 2005 May; 99(5):341-6. PubMed ID: 15780340
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
